Syntaxin-6 promotes the progression of hepatocellular carcinoma and alters its sensitivity to chemotherapies by activating the USF2/LC3B axis

por Zhou, Lianer, Wang, Zhenyu, Chen, Xiaoxia, Li, Xianxian, Ge, Chao, Min, Xuejie, Zhao, Fangyu, Chen, Taoyang, Li, Jinjun
Publicado 2023

FBXO9 Mediates the Cancer-Promoting Effects of ZNF143 by Degrading FBXW7 and Facilitates Drug Resistance in Hepatocellular Carcinoma

por Wang, Zhenyu, Chen, Xiaoxia, Zhou, Lianer, Zhao, Xinge, Ge, Chao, Zhao, Fangyu, Xie, Haiyang, Chen, Taoyang, Tian, Hua, Li, Hong, Li, Jinjun
Publicado 2022